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ABSTRACT The nucleotide sequences of 27 T-cell recep-
tor a-chain variable region (V.)-containing cDNA clones
isolated from a cDNA library derived from human peripheral
blood lymphocytes were determined. Eighteen different V. and
26 different joining (J.) gene segments are utilized in these
clones. The Va gene segments belong to 12 different subfami-
lies, each containing from one to seven members. Comparisons
with the 16 different V. and 21 different Ja sequences previ-
ously reported suggest that the germ-line repertoires for these
gene segments are greater than previously estimated. Flexibil-
ity in the sites of gene segment joining and possibly N-region
diversification also contribute to human a-chain diversity.
Comparisons of human V. regions indicate a high degree of
variability spread uniformly across the entire V. region with-
out obvious hypervariable regions. However, amino acids
important for the maintenance of V gene structure are con-
served.
and either six or seven J4 segments (12-14). Statistical
analyses of pools of Va gene segments suggest that the mouse
has 20-30 (15, 16) and humans have -60 V1,3 gene segments
(17-19).
In the mouse, we identified 40 VY. and 18 Ja, gene segment
sequences through nucleotide sequence analysis and hybrid-
ization techniques (6). An analysis of 21 human V,,, genes from
a cDNA library derived from the peripheral lymphocytes of
a single individual suggested that there were only 40 Vat and
<55 Ja gene segments (20). Because the gene segments in this
initial analysis did not appear to be randomly distributed,
statistical estimates of germ-line diversity were unreliable.
Therefore, we examined 27 Va genes from a peripheral
lymphocyte cDNA library derived from a second individual.
This analysis indicates that the human Va and Ja repertoires
may be substantially larger than previously estimated.§
The T-cell antigen receptor (TCR) functions to recognize
foreign macromolecules (antigens) presented by accessory
cells in the context of molecules encoded by the major
histocompatibility complex (1). The TCR is displayed on the
surface ofT cells as a disulfide-linked a-/,8-chain heterodimer
(2, 3). Each chain is divided into a variable (V) region that
recognizes antigen and a constant (C) region that attaches the
V region to the cell surface. The Va regions are encoded by
discontinuous Va and joining (Ja) gene segments that recom-
bine during T-cell differentiation to create functional V",
genes (4, 5). Likewise, the V,3 regions are encoded by
rearranging Vq3, diversity (Do), and J4 gene segments that
form Vat genes (6-11). The TCR must be capable ofenormous
diversification to recognize the universe of foreign antigens.
This diversification occurs by four major somatic mecha-
nisms: (i) combinatorial joining of any V to any D or J gene
segment, (ii) flexibility in the positions within the gene
segments at which joining occurs (junctional diversity), (iii)
insertion of non-germ-line nucleotides into the junctions
during joining (N-region diversity), (iv) combinatorial asso-
ciation of any a chain with any ,8 chain. Somatic hypermuta-
tion does not seem to play a significant role in generating TCR
diversity (11). Therefore, it is important to have an accurate
estimate of the total number of germ-line gene segments and
to understand the somatic mechanisms that operate to gen-
erate variability in order to estimate the true range of
potentially expressed TCR diversity.
There is substantial information regarding the number of f8
gene segments in humans and mice. Each has two D-Jp-Cs3
clusters. These clusters contain single Dq3 and Cal elements
MATERIALS AND METHODS
Isolation of a-Chain cDNA Clones. A Pvu II restriction
fragment corresponding to the Ca region from the cDNA
clone PY14 (21) was used to screen a phytohemagglutinin-
stimulated human peripheral lymphocyte cDNA library (17).
Phage DNAs from Ca-positive plaques were purified on
DEAE columns (22). EcoRI-excised cDNA inserts were
sized on 0.7% agarose gels and those >1.5 kilobases (kb) long
were subcloned into the EcoRI site of M13mpl8. Orientation
of inserts in M13mpl8 was determined by hybridization with
strand-specific oligonucleotide probes.
DNA Sequence Analysis. The nucleotide sequences of the
Va, and Ja regions of the isolated cDNA clones were deter-
mined by the Sanger et al. method (23). DNA sequence
reactions were primed with a Ca-specific oligonucleotide
primer and with the M13 universal sequencing primer. All
nucleotide sequences reported were determined multiple
times on each strand.
Southern Blot Analysis. EcoRI inserts for use as hybrid-
ization probes were isolated from M13 phage clones by
freeze-thaw and phenol extraction from low melting temper-
ature agarose gels. Blots of EcoRI- and BamHI-digested
human germ-line DNA were prepared on nylon membranes
(Gelman Scientific) by the procedure of Reed and Mann (24)
and hybridized as described (25).
Abbreviations: TCR, T-cell antigen receptor; MHC, major histo-
compatibility complex; V, C, J, and D, variable, constant, joining,
and diversity regions.
tOn leave sabbatical from the Toronto Western Hospital, Toronto,
Canada.
§These sequences are being deposited in the EMBL/GenBank data
base (Bolt, Beranek, and Newman Laboratories, Cambridge, MA,
and Eur. Mol. Biol. Lab., Heidelberg) (accession no. J02992).
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RESULTS
Va Gene Segment Repertoire. We randomly selected 30
cDNA clones isolated from a cDNA library constructed from
phytohemagglutinin-stimulated human peripheral blood lym-
phocytes with a Ca probe and determined their nucleotide
sequences. Twenty-seven of these clones contained nucleo-
tide sequences derived from a V,, gene segment. Their
sequences are presented in Fig. 1. There are 18 unique Va,
gene segments represented among these sequences, 12 of
which have not been previously reported. These sequences
bring to 28 the total number of different human Va gene
segments that have been directly identified by nucleotide
sequence analysis. Some Va gene segments were frequently
isolated. For example, the Va1.2 gene segment is used in 6 of
the 27 clones listed in Fig. 1. The Va2.1 and Va2.2 gene
segments are used two and four times, respectively. In a
similar analysis, Yoshikai et al. (20), isolated four clones out
of 21 containing the Va,11.1 and three clones containing the
Va8.1 gene segments. In contrast, we isolated only a single
VaJ.J-containing clone and saw no examples of the Va8.1
gene segment. These observations demonstrate that the
distribution of Va gene segments among the sequences
reported here, or when pooled with those previously de-
scribed (20), is nonrandom. Hence, it is not possible to use
statistical methods to estimate the expressed Va gene seg-
ment repertoire size. The fact that 28 different Va gene
segments have been derived from 49 independently selected
cDNA clones certainly suggests that the germ-line repertoire
is much larger than 40.
The nucleotide sequences of three additional clones were
also determined (data not shown). Two of these appear to be
germ-line Ja transcripts (26), extending through the Ja gene
segment and containing the heptamer and nonamer se-
quences that mediate gene rearrangement as well as addi-
tional 5' flanking DNA. The third clone contained only a
truncated Ca transcript.
Va Gene Segment Subfamilies. Subfamilies of V gene
segments are defined as groups of V gene segments that share
at least 75% nucleotide identity. Twelve different human Va
gene segment subfamilies have been defined thus far (20).
The 18 different Va gene segment sequences we report here
include 12 novel Va sequences and 6 that have been previ-
ously identified. These additional Va gene segments define 7
Va gene segment subfamilies, VaJ3-Va19 by the nomencla-
ture of Yoshikai et al. (20), and provide nucleotide sequence
information for three new members of the Val subfamily and
two new members of the Va2 subfamily. To determine the
sizes of these Va subfamilies, we used cDNA clones each
containing a Va gene segment from one subfamily to probe
human germ-line DNA on genomic blots (Fig. 2). Two
different restriction digests (EcoRI and BamHI) were probed
to clearly establish how many hybridization bands corre-
sponded to distinct Va gene segments. These subfamilies
appear to include only one or two members under hybrid-
ization conditions that yielded similar results to those report-
ed by Yoshikai et al. (20) for the sizes of subfamilies Val and
Va2. There are three subfamilies with two members (Va13,
Va16, and Va18) and four single-member subfamilies (Va14,
ValS, Va17, and Va19). The hybridization pattern with clone
AD2.10 (Va19.1) was consistent with it representing a new Va
gene segment subfamily, although the amount of available
nucleotide sequence is limited and derived from the most
conserved portion of the Va gene segment. As a result, this
clone shares apparently artifactual nucleotide identity with
members of five different Va subfamilies. A total of 48 Va
gene segments could be estimated from the analysis of
hybridization experiments reported here and previously
(20).
Structure of Va Gene Segments. The translated amino acid
sequences of human Va gene segments from subfamilies
VaJ-Val9 are aligned and displayed in Fig. 3. The protein
sequence similarity between different Va gene segment
subfamilies ranges from 16% to 58%, in the same range as that
observed in comparisons of similarly aligned human Va
subfamily representatives. Despite this extreme range of
variability, a series of 10 amino acid positions known to be
important for the maintenance of the protein structure char-
acteristic of immunoglobulin V domains, indicated by aster-
isks in Fig. 3, are conserved by >75% of characterized Va and
Va gene segments (1). Conservation of these positions as well
as five others can also be seen in comparisons between
human and murine Va gene segments (5).
A great range of variability in the choice of amino acid
residues without compromise of structure and function is
characteristic of V regions of immunoglobulin and T-cell
receptor chains. The distribution of variability, position by
position, along the primary structure of the molecules is
typically nonrandom when V-region amino acid sequences
are aligned and compared. The standard means by which this
distribution is displayed is through the use of variability plots
based on the algorithm ofWu and Kabat and coworkers (27, 28).
In these plots, most V-region families reveal the presence of
three or four regions of relative hypervariability. These regions
correspond to sites of antigen contact in immunoglobulin
molecules (27, 28) and peaks at similar positions occur in human
Va regions (17-19). However, such an analysis (not shown) for
Va sequences as aligned in Fig. 3 fails to reveal obvious
hypervariable regions other than at the Vaa-J junction where
somatic mutation mechanisms generate extensive diversity.
While this result does not preclude that Va regions use similar
sites for antigen recognition, it does indicate that variability is
more uniformly distributed in Va regions than in the sample of
other known V regions, making detection of potential antigen
combining sites by this technique more difficult.
J. Contributions to Diversity. There are 26 different Ja gene
segments found in 29 Ja-containing cDNA clones whose
nucleotide sequences we determined. One clone is nonpro-
ductive by virtue of having incorporated a germ-line Ja
pseudogene (APS11). Ja gene segment usage appears to be
random with respect to combinatorial joining to Va gene
segments. For example, each of the six different cDNA
clones we examined that utilized the Va1.2 gene segment
used a different Ja gene segment. From this distribution ofJa
a gene usage, a statistical calculation (15) indicates that there
may be 100 or more germ-line Ja gene segments. When these
Ja gene segments are added to those previously reported (20,
26), a total of 37 different Ja gene segments have been
identified.
On average, human Ja gene segments are longer than their4
counterparts, primarily at the 5' end. Ja and J4 segments share
a highly conserved core sequence Phe-Gly-Xaa-Gly-Thr-Xaa-
Leu-Xaa-Val, where Xaa can be any amino acid. Despite this
protein conservation, the Ja gene segments are highly variable
at the nucleotide level, with an average nucleotide identity
ranging from 40% to 60%o. Hence, none of the human Ja gene
segments sequenced appear to be simple alleles, nor can any be
grouped into subfamilies as can the Va gene segments.
Within the cDNA clones, variability is particularly great at
the 5' end of the Ja gene segments. A comparison of Ja
sequences within isolated cDNA clones to those germ-line Ja
gene segment sequences available indicates that some of this
variability results from flexibility at the sites at which the
gene segments are joined (Fig. 4). Also, a comparison of the
sequences of two Val .2-containing clones (PY14 and AB17)
to the germ-line sequence of Va1.3 and the appropriate Ja
gene segments reveals the presence of nucleotides at thejunctions not encoded in either germ-line sequence. These
nucleotides most likely reflect N-region diversification (29),
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AC 17 GTTCCAGAGGGAGCCATTGTTTCTCTCAACTGCACTTACAGCAACAGTGCTTTT CAATACTTCATGTGGTACAGACAGTATTCCAGAATAGGCCCTGAGTTGCTGATGTACACA
AA25 GTTCCAGAGGGAGCCACTGTCGCTTTCAACTGTACTTACAGCAACAGTGCTTCT CAGTCTTTCTTCTGGTACAGACAGGATTGCAGGAAAGAACCTAAGTTGCTGATGTCCGTA
AG2 12 GTCCAGGAGGGTGACAACTCTATTATCAACTGTGCTTATTCAAACAGCGCCTCA GACTACTTCATTTGGTACAAACAAGAATCTGGAAAAGGTCCTCAATTCATTATAGAC
AB19 TCTTCA$AGGGAGCTGTGGTGGAAATCTTCTGTAATCACTCTGTGTCCAATGCT TACAACTTCTTCTGGCACCTTCACTTCCCGGGATGTGCACCAAGACTCCTTGTTAAA
AC25 GG














AC17 TACTCCAGTGGTAAC AAAGAAGATGGAAGGTTTACAGCACAGGTCGATAAATCCAGCAAGTATATCTCCTTGTTCATCAGAGACTCACAGCCCAGTGAT TCAGCCACCTACAD17 GGTAAC AAAGAAGATGGAAGGTTTACAGCACAGGTCGATAAATCCAGCAAGTATATCTCCTTGTTCATCAGAGACTCACAGCCCAGTGAT TCAGCCACCTAC
AA25 TACTCCAGTGGT AATGAAGATGGAAGGTTTACAGCACACGTCAATAGAGCCAGCCAGTATATTTCCCTGCTCATCAGAGACTCCAAGCTCAGTGATTCAGCCACCTAC
AG212 ATTCGTTCAAATATGGACAAA AGGCAAGGCCAAAOAGTCACCGTTTTATTGAATAAGACAGTGAAACATCTCTCTCTGCAAATTGCAOCTACTCAACCTGGAGACTCAGCTGTCTAC
ABI9 GGCTCAAAGCCT TCTCAGCAGGGACGATACAACATGACCTATGAA CGGTTCTCTTCATCGCTGCTCATCCTCCAGGTGCGGGAGGCAGATGCTGCTGTTTAC
AC25 AACTCTTTTGATGAGCAAAAT GAAATAAGTGGTCGGTATTCTTGGAACTTCCAGAAATCCACCAGTTCCTTCAACTTCACCATCACAGCCTCACAAGTCGTGGACTCAGCAGTATAC




















AA 13 CTCTGTGCAATG GGACCTAACTTTGGAAATGAGAAATTAACCTTTGGGACTGGAACAAGACTCACCATCATACCCAATATCC
AGII10 CTCTGTQCAATGAGCG GTAGAGGCTCAACCCTGGGGAGGCTATACTTTGGAAGAGGAACTCAGTTGACTGTCTGGCCTGATATCCAGAACCC
AC 17 CTCTGTGCAATGAGCG COAGAGCAGGCAACATGCTCACCTTTGGAGGGGGAACAAGGTTAATGGTCAAACCCCATATCCAG
AD17 CTCTGTGCAATGAGCG CTTATTCAGGATACAGCACCCTCACCTTTGGGAAGGGGACTATGCTTCTAGTCTCTCCAGATATCCAGAACCCAA25 CTCTGTGTGGTGAAC ATTCGCCCAGGAAACACACCTCTTGT CTT GGAAAGGGCACAAGACTTTCTGTGATTCCAAATATCC
AG212 TTTTGTGCAGAGACG TATTCTGGGGGTTACCAGAAAGTTACCTTTGGAATTGGAACAAAGCTCCAAGTCATCCCAAATATCC
ABI9 TACTGTGCTGTGG CCTGGACGGGCAGGAGAGCACTTACTTTTGGGAGTGGAACAAGACTCCAAGTGCAACCAAATATCC







FIG. 1. Nucleotide sequences of human Va gene segments. Nucleotide sequences were translated and aligned to maximize amino acid
identity. Sequences previously reported (4, 20) were included in this analysis and are responsible for the positioning of some gaps but are not
shown. The 3' ends of Va gene segments were assigned as the last nucleotide of continuous identity between multiple examples of the same
V. gene segment or V, segments from the same subfamily. Clones AB11-AD210 correspond to V,,, gene segment subfamilies V13-VaJ9.
although polymorphism or the presence ofa D<,, gene segment
cannot be excluded (Fig. 4). However, no conserved junc-
tional sequences that might indicate at least a limited number
of D,,, elements are observed.
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FIG. 2. Southern blot analysis of human germ-line DNA with V. gene probes. HeLa cell DNA was digested with EcoRI (R) and BamHI (B),
electrophoresed, blotted to nylon membranes, and hybridized with cDNA clones containing the indicated V<,, gene segments. Vertical lines below
the gels represent the estimated number of members within the indicated V,, gene segment subfamily.
DISCUSSION
We have reported here the analysis of 30 a-chain cDNA
clones isolated from a library constructed from phytohemag-
glutinin-stimulated human peripheral blood lymphocytes.
These clones contain 18 different V, gene segments, 12 of
which have not been previously identified. These Va gene
segments define seven Va gene segment subfamilies, Va13 to
Va19. The Va gene segments are not randomly utilized in
these clones. Twenty-six different Ja gene segments are
utilized in these cDNA clones, 16 of which have not been
seen previously. We draw several conclusions from these
data. First, the human germ-line Va gene segment repertoire
is substantially larger than previously reported. Nonrandom
expression of the germ-line repertoire compromises our
ability to estimate the total size of the repertoire by statistical
methods. However, the fact that we see 28 different V0 gene
segments in 49 a cDNA clones suggests the repertoire is
substantially greater than 40. The same is not true of human












Va 4.1 AKTTO PNSMESNEEEPVHLPCNHSTISGT
Va5.1 EALNIQEGKTATLTCNYTNYSP
V06.1 OKITOTOPGMFVQEKEAVTLDCTYDTSDOS
V. 7.1 QSLEG PSEVTAVEGAIVOINCTYOTSGF













gene segments may reflect distinct patterns of T-cell clonal
expansion due to distinct antigenic histories. It is interesting
that Ja gene segment expression does not appear to be as
significantly constrained. This may imply that somatic vari-
ation at the Va-Ja junction is more critical to antigen/major
histocompatibility complex specificity than are particular JtT
gene segments. Second, although the range of variability
between V1 regions is similar to that observed between V's
regions on a percentage basis, V, variability is distributed
more uniformly along the primary sequence. Obvious
hypervariable regions that are often observed for other V
gene segment families are not detected. Third, the total
number of Ja, gene segments identified by direct nucleotide
sequencing is 37. Based on their apparently random usage in
the clones we have studied, we estimate that there may be on
the order of 100 J,, sequences. Fourth, comparison of J.
sequences in the cDNA clones we have isolated to known
germ-line Ja, gene segment sequences provides evidence for
a significant role forjunctional and probably N-region diver-
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FIG. 3. Amino acid sequences of human Va gene segments. Representative nucleotide sequences for each of the different human Va gene
segment subfamilies were translated and aligned to maximize identity. The Va1.1, -1.3, -3.1, -4.1, -5.1, -6.1, -7.1, -7.2, -8.1, -9.1, and -10.1 gene
segments were derived from published sequences (4, 20). Asterisks indicate residues conserved at the 75% level in a comparison ofhuman Va,





























I- N or D Region - | Junctionol
FIG.4. Diversity at the Vf-J junction. Clones PY14 and AB17 each contain the V/,1.2 gene segment (21) and either the JaA or JaB sequence
(26), respectively. The germ-line sequence for the V141.3 gene segment, which is >90%o identical to V41.2, is indicated as PY14.2 germ line (26)
as are germ-line sequences for JaA and JB gene segments. N or D region, nucleotides within the cDNA clones that cannot be accounted for
by reference to germ-line sequences; Junctional, nucleotides from Jaf gene segments not represented within the cDNA clones.
sification mechanisms in human Va chain gene diversifica-
tion.
A minimal estimate of the number of potential human TCR
a-/(3-chain heterodimers can be derived by simple multipli-
cation of germ-line gene segment numbers assuming that
germ-line pseudogenes are infrequent and that all possible
combinations both at the level of gene segment rearrange-
ment and the level ofchain association are permitted. Current
nucleotide sequences of human V0 gene segments and ge-
nomic blot analyses with V0 subfamily probes provide firm
evidence for the existence of at least 48 human V0 gene
segments. The infrequent occurrence of pseudogenes in the
fully characterized sequences may argue that most of these
are functional V, gene segments. Given the limited overlap
(6/18) in Va, gene segment usage in our analysis and that of
Yoshikai et al. (20), it is likely that substantially more V0, gene
segments may exist. Nucleotide sequence analyses indicate
the existence ofat least 37 different Ja gene segments, and we
have estimated, based on distribution, that there could be
more than 100 such segments. Therefore, we can calculate
that there are minimally 50 x 100 or 5000 possible a chains.
A similar calculation for the (3 chain utilizing a germ-line
repertoire of 60 Vp gene segments, two D9 gene segments
used in all three reading frames, and 13 functional Jp gene
segments in two clusters yields =3500 possible (8 chains.
Assuming random association of a and ,3 chains, there are
potentially 1.8 x 107 possible heterodimers. This calculated
value is similar to that derived for murine T-cell receptors and
immunoglobulins (30). When somatic variation is considered,
it becomes clear that B cells and T cells have the potential to
code for similar numbers of antigen-receptor molecules.
Note Added in Proof. Kimura et al. (31) have recently published the
nucleotide sequences of additional human Vs-containing cDNA
clones.
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